Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 569 participants.

Also called NCT01768208

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking
Phase
Phase 4
Enrolled
  • 569 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01768208
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01768208. Allocation not applicable; no masking. Start 2012-10 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
Intervention (Drug)
Saxagliptin
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01768208
Content hash
78c66dfb370f4cdf01dece41ba8bca8967584493f50529cdc498667f25741b8d